期刊文献+

鼻咽癌的放化疗综合治疗 被引量:7

原文传递
导出
摘要 随着医学影像学、放射生物学及放射物理学的发展和临床经验的积累,早期鼻咽癌(Ⅰ、Ⅱ期)患者的5年生存率已达60%~90%,而晚期(Ⅲ、Ⅳ期)患者的5年生存率仅40%左右,治疗失败的主要原因为远处转移和局部复发。近年来调强适形放射治疗的应用,使鼻咽癌的疗效明显提高,但如何进一步降低局部复发和远处转移,放化疗综合治疗就成为研究的热点。
作者 张学成 石梅
出处 《中华放射医学与防护杂志》 CAS CSCD 北大核心 2007年第6期610-613,共4页 Chinese Journal of Radiological Medicine and Protection
  • 相关文献

参考文献20

  • 1Huneharek M, Kupelnick B. Combined chemotherapy versus radiation therapy alone in locally advanced nasopharyngeal carcinoma. Am J Clin Oncol,2002,23(3) :219-223.
  • 2Bertrand B, Hélène A, Jean B, et al. Chemotherapy in locally advanced nasopharyngeal carcinoma: An individual patient data meta- analysis of eight randomized trials and 1753 patients. Int J Radiat Oneol Biol Phys, 2006,64( 1): 47-56.
  • 3Chaa DT, Ma J, Sham JS, et al. Long-term survival after cisplatin- based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase Ⅲ trails. J Clin Oncol, 2005, 23:1059-1060.
  • 4Chua DT, Sham J, Wei W,et al. Control of regional metastasis after induction chemotherapy and radiotherapy for nasopharyngeal carcinoma. Head Neck, 2002,24 (4) : 350-360.
  • 5Hareyama M, Sakata K, Shirato H, et al. A prospective, randomized trial comparing neoadjuvant chemotherapy with radiotherapy alone in patients with advanced nasopharyngeal carcinoma. Cancer, 2002,94 (8):2217-2223.
  • 6International Nasopharynx Cancer Study Group, VUMCA I TriM. Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs radiotherapy alone in stage IV (> N1, M0 ) undifferentiated nasopharyngeal carcinoma: a positive effect on progression-free survival. Int J Radiat Oncol Biol Phys, 1996,35(3) :463-469.
  • 7严洁华 徐国镇 见:殷蔚伯 谷铣之主编.鼻咽癌[A].见:殷蔚伯,谷铣之主编.肿瘤放射治疗学[C].北京:中国协和医科大学出版社,2002.559-562.
  • 8Ma BB, Chan AT. Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinoma. Cancer, 2005, 103: 22-31.
  • 9Lee AW, Tung SY, Chan AT. Preliminary results of a randomized study (NPC-9902 Trial ) on therapeutic gain by concurrent chemotherapy and/or accelerated fractionation for locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Phys, 2006, 66: 142- 151.
  • 10Chan AT, Tee TM, Ngan RK, et al. Concurrent chemotherapy- radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: progression-free survival analysis of a phase III randomized trial. J Clin Oncol, 2002,20(8): 2038- 2044.

共引文献25

同被引文献57

引证文献7

二级引证文献91

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部